SCHEMBL1454451

SCHEMBL1454451

C[CH]CCCCC(CC)Oc1ccccc1

nearest known ligand 0.41

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SLC7A5 Q01650 1/20 0.36
SLC6A4 P31645 1/20 0.34
PPARG P37231 3/20 0.33
PPARA Q07869 3/20 0.33
ADRA2A P08913 1/20 0.33
ADRA2B P18089 1/20 0.33
ADRA2C P18825 1/20 0.33
MAOA P21397 1/20 0.33
MAOB P27338 1/20 0.33
NISCH Q9Y2I1 1/20 0.33
POLB P06746 1/20 0.32
TDP1 Q9NUW8 1/20 0.32
LTA4H P09960 1/20 0.32
KDM4E B2RXH2 1/20 0.31
TSHR P16473 1/20 0.31
ALDH1A1 P00352 1/20 0.31
KCNA3 P22001 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1455116 0.95 SLC6A4 (0.35) SLC7A5SLC6A4PPARGPPARAADRA2A
SCHEMBL1455125 0.88 SLC6A4 (0.37) SLC7A5SLC6A4PPARGPPARAADRA2A
SCHEMBL20271344 0.84 TSHR (0.36) SLC7A5SLC6A4PPARGPPARAADRA2A
SCHEMBL9992781 0.83 LTA4H (0.44) SLC7A5SLC6A4PPARGPPARAADRA2A
SCHEMBL28174310 0.81 LTA4H (0.43) SLC7A5SLC6A4ADRA2AADRA2BADRA2C
SCHEMBL28199477 0.81 LTA4H (0.43) SLC7A5SLC6A4ADRA2AADRA2BADRA2C
SCHEMBL8766939 0.81 LTA4H (0.43) SLC7A5SLC6A4ADRA2AADRA2BADRA2C
SCHEMBL27510040 0.81 LTA4H (0.43) SLC7A5SLC6A4ADRA2AADRA2BADRA2C
SCHEMBL27438936 0.81 LTA4H (0.44) SLC7A5SLC6A4PPARGPPARALTA4H
SCHEMBL1454048 0.81 KMT2A (0.35) PPARGPPARAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7910617-B2 Method for suppressing the number of peripheral blood lymphocytes using an amino alcohol compound SANKYO COMPANY, LIMITED (JP) 2011-03-22 US disclosed
US-20070191468-A1 Amino alcohol compound DAIICHI SANKYO COMPANY, LIMITED (JP) 2007-08-16 US disclosed
EP-1733724-A1 AMINO ALCOHOL COMPOUND Sankyo Company, Limited (JP) 2006-12-20 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070191468-A1 Amino alcohol compound ADH1A, ADH1C, BCAT1 SLC7A5 16/4885SLC6A4 1912/4885PPARG 388/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.